#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Hemorrhagic shock and treatment of severe bleeding


Authors: Dagmar Seidlová 1;  Alena Buliková 2,3
Authors‘ workplace: II. anesteziologicko-resuscitační oddělení a Klinika anesteziologie, resuscitace a intenzivní medicíny LF MU a FN Brno 1;  Oddělení klinické hematologie FN Brno 2;  LF MU Brno 3
Published in: Vnitř Lék 2019; 65(3): 211-218
Category:

Overview

Hemorrhagic shock is a severe complication of conditions that are accompanied by massive bleeding and is associated with high mortality and morbidity. The authors summarize the recent knowledge in the pathophysiology of coagulopathy in the course of its development and some options in treatment strategy

Keywords:

diagnosis – Etiology – treatment


Sources
  1. Kozek-Langenecker SA et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol 2017; 34(6): 332–395. Dostupné z DOI: <http://dx.doi.org/10.1097/EJA.0000000000000630>.

  2. Rossaint R, Bouillon B, Cerny V et al. The European guideline on management of major bleeding and coagulopathy following trauma. Critical care 2016; 20: 100. Dostupné z DOI: <http://dx.doi.org/10.1186/s13054–016–1265-x>.

  3. Blatný J, Bláha J, Cvachovec K et al. Diagnostika a léčba život ohrožujícího krvácení u dospělých pacientů v intenzivní a perioperační péči, Česko-slovenský mezioborový doporučený postup. Anesteziologie a intenzivní medicína 2017; 28(4): 263–269.

  4. Kokrdová Z, Křepelka P, Kvasnička J et al. Diagnostika a léčba peripartálního život ohrožujícího krvácení. Česká gynekologie 2018; 83(2): 152–158.

  5. Noel P, Cashen S, Patel B. Trauma-induced coagulopathy: from biology to therapy. Sem Hematol 2013; 50(3): 259–269. Dostupné z DOI: <http://dx.doi.org/10.1053/j.seminhematol.2013.06.009>.

  6. Buliková A, Matýšková M, Penka M. Léčba krvácení transfuzními přípravky a krevními deriváty. Vnitř Lék 2008; 54(6): 623–631.

  7. Sornsen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 2011; 99(Suppl 1): S40-S50. Dostupné z DOI: <http://dx.doi.org/10.1002/bjs.7770>.

  8. De Robertis E, Kozek-Lanfenecker A, Tufano R et al. Coagulopathy induced by acidosis, hypothermia and hypocalceaemia in severe bleeding. Minerva Anesteosiol 2015; 81(1): 65–75.

  9. Martini WZ. Coagulopathy by hypothermia and acidosis: Mechanisms of thrombin generation and fibrinogen availability. J Trauma 2009; 67: 202–208; discussion 208–209. Dostupné z DOI: <http://dx.doi.org/10.1097/TA.0b013e3181a602a7>.

  10. Kheirbek T, Kocharek AR, Alam HB. Hypothermia in bleeding trauma: a friend or a foe? Scand J Trauma Recus Emerg Med 2009; 17: 65. Dostupné z DOI: <http://dx.doi.org/10.1186/1757–7241–17–65>.

  11. Mitrophanov AY, Rosendaal FR, Reifmann J. Computational analysis of the effects of reduced temperature on thrombin generation: the contribution of hypothermia to coagulopathy. Anesth Analg 2013; 117(3): 565–574. Dostupné z DOI: <http://dx.doi.org/10.1213/ANE.0b013e31829c3b22>.

  12. Wolberg AS, Meng ZH, Monroe DM et al. A systemic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Traum 2004; 56(6): 1221–1228.

  13. Noel P, Cashen S, Patel B. Trauma-induced coagulopathy: from biology to therapy. Sem Hematol 2013: 50(3) 259–269. Dostupné z DOI: <http://dx.doi.org/10.1053/j.seminhematol.2013.06.009>.

  14. James MF, Roche AM. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothorac Vas Anesth 2004; 18(5): 581–586.

  15. Valeri CR, Cassidy G, Pivacek LE et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 2001; 41(8): 977–983.

  16. Fowler AJ, Ahmad T, Phull M et al. Meta‐analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg 2015; 102(11): 1314–1324. Dostupné z DOI: <http://dx.doi.org/10.1002/bjs.9861>.

  17. Baron DM, Hochrieser H, Posch H et al. [European Surgical Outcomes Study (EuSOS) group for Trials Groups of European Society of Intensive Care Medicine; European Society of Anaesthesiology]. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 2014; 113(3): 416–423. Dostupné z DOI: <http://dx.doi.org/10.1093/bja/aeu098>.

  18. Spahn DR, Zacharowski K. Non-treatment of preoperative anaemia is substandard clinical practice. Br J Amaesth 2015; 115(1): 1–3. Dostupné z DOI: <http://dx.doi.org/10.1093/bja/aev099>.

  19. Charbit B, Mandelbrot L, Samain E et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5(2): 266–273. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1538–7836.2007.02297.x>.

  20. Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 54(5): 1389–1405. Dostupné z DOI: <http://dx.doi.org/10.1111/trf.12431>.

  21. Chee YL, Greaves M. Role of coagulation testing in predicting bleeding risk. Hematol J 2003; 4(6): 373–378. Dostupné z DOI: <http://dx.doi.org/10.1038/sj.thj.6200306>.

  22. Hsu JM, Pham TN. Damage control in the injured patient. Int J Crit Illn Inj Sci 2011; 1(1): 66–72. Dostupné z DOI: <http://dx.doi.org/10.4103/2229–5151.79285>.

  23. Martinelli T, Thony F, Declety P et al. Intra-aortic balloon occlusion to salvage patients with life-threatening hemorrhagic shocks from pelvic fractures. J Trauma 2010; 68(4): 942–948. Dostupné z DOI: <http://dx.doi.org/0.1097/TA.0b013e3181c40579>.

  24. Vincent JL, Dufaye P, Berre J et al. Serial lactate determinations during circulatory shock. Crit Care Med 1983; 11(6): 449–451.

  25. Hébert PC, Wells G, Blajchman H et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. N Engl J Med 1999; 340(6): 409–417. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJM199902113400601>. Erratum in N Engl J Med 1999; 340(13): 1056.

  26. McIntyre L, Hebert PC, Wells G et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma 2004; 57(3): 563–568.

  27. Phelan HA, Gonzalez RP, Patel H et al. Prestorage leukoreduction ameliorates the effects of aging on banked blood. J Trauma 2010; 69(2): 330. Dostupné z DOI: <http://dx.doi.org/10.1097/TA.0b013e3181e0b253>.

  28. Roberts I, Shakur H, Afolabi A et al. [Crash-2 Collaborators]. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377(9771): 1096–1101, 1101.e1–2. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(11)60278-X>.

  29. Fenger-Eriksen C, Lindberg-Larsen M et al. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101(6): 769–773. Dostupné z DOI: <http://dx.doi.org/10.1093/bja/aen270>.

  30. Innerhofer P, Fries D, Mittermayr M et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol 2017; 4(6): 258–271. Dostupné z DOI: <http://dx.doi.org/10.1016/S2352–3026(17)30077–7>.

  31. Schöchl H, Nienaber U, Hofer G et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14(2): R55. Dostupné z DOI: <http://dx.doi.org/10.1186/cc8948>.

  32. Nardi G, Agostini V, Rondinelli B et al. Traumainduced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. Crit Care 2015; 19: 83. Dostupné z DOI: <http://dx.doi.org/10.1186/s13054–015–0817–9>.

  33. Scalea TM, Bochicchio KM, Lumpkins K et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg 2008; 248(4): 578–584. Dostupné z DOI: <http://dx.doi.org/10.1097/SLA.0b013e31818990ed>.

  34. Marietta M, Franchini M, Bindi H et al. Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus document. Blood Transfus 2016; 14(4): 277–286. Dostupné z DOI: <http://dx.doi.org/10.2450/2016.0168–15>.

  35. Dutton RP, McCunn M, Hyder M et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004; 57(4): 709–718; discussion 718–719.

  36. Blatný J, Seidlová D, Penka M et al. Severe postpartum haemorrhage treated with recombinant activated factor VII in 80 Czech patients: analysis of the UniSeven registry.Int J Obstet Anesth 2011; 20(4): 367–368. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijoa.2011.07.008>.

  37. Sorensen B, Spahn DR, Innerhofer P et al. Clinical review: prothrombin complex concentrates–evaluation of safety and thrombogenicity. Crit Care 2011; 15(1): 201–217. Dostupné z DOI: <http://dx.doi.org/10.1186/cc9311>. Erratum in Crit Care 2011; 15(2): 409.

  38. Breuer G, Weiss DR, Ringwald J. “New” direct oral anticoagulants in the perioperative setting. Curr Opin Anaesthesiol 2014; 27(4): 409–419. Dostupné z DOI: <http://dx.doi.org/10.1097/ACO.0000000000000100>.

  39. Aronis KN, Hylek EM. Who, when, and how to reverse non-vitamin K oral anticoagulants. J Thromb Thrombolysis 2016; 41(2): 253–272. Dostupné z DOI: <http://dx.doi.org/10.1007/s11239–015–1297–0>.

Labels
Diabetology Endocrinology Internal medicine
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#